Savant Capital LLC Has $2.91 Million Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

Savant Capital LLC lifted its stake in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 81.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,755 shares of the company's stock after acquiring an additional 3,943 shares during the quarter. Savant Capital LLC's holdings in Medpace were worth $2,909,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of MEDP. Centaurus Financial Inc. increased its position in Medpace by 2.0% during the third quarter. Centaurus Financial Inc. now owns 1,513 shares of the company's stock worth $505,000 after buying an additional 29 shares during the last quarter. Lindenwold Advisors INC increased its position in Medpace by 1.6% during the third quarter. Lindenwold Advisors INC now owns 2,026 shares of the company's stock worth $676,000 after buying an additional 32 shares during the last quarter. Stephens Inc. AR increased its position in Medpace by 4.9% during the fourth quarter. Stephens Inc. AR now owns 752 shares of the company's stock worth $250,000 after buying an additional 35 shares during the last quarter. M&T Bank Corp increased its position in Medpace by 1.2% during the third quarter. M&T Bank Corp now owns 3,199 shares of the company's stock worth $1,068,000 after buying an additional 37 shares during the last quarter. Finally, Custom Index Systems LLC boosted its holdings in Medpace by 3.0% during the fourth quarter. Custom Index Systems LLC now owns 1,290 shares of the company's stock valued at $429,000 after acquiring an additional 37 shares during the period. 77.98% of the stock is owned by institutional investors and hedge funds.

Medpace Price Performance

Shares of NASDAQ MEDP traded down $2.24 during mid-day trading on Friday, hitting $340.17. The company had a trading volume of 299,085 shares, compared to its average volume of 208,882. The business's 50-day simple moving average is $343.50 and its 200-day simple moving average is $348.31. Medpace Holdings, Inc. has a 12 month low of $302.01 and a 12 month high of $459.77. The firm has a market cap of $10.57 billion, a P/E ratio of 29.79, a PEG ratio of 1.85 and a beta of 1.36.

Medpace (NASDAQ:MEDP - Get Free Report) last released its earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 17.66% and a return on equity of 50.87%. As a group, sell-side analysts predict that Medpace Holdings, Inc. will post 11.93 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on MEDP. Baird R W cut shares of Medpace from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 23rd. William Blair restated an "outperform" rating on shares of Medpace in a report on Tuesday, October 22nd. Robert W. Baird upped their price target on shares of Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Finally, TD Cowen decreased their price target on shares of Medpace from $413.00 to $372.00 and set a "buy" rating for the company in a report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $381.44.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.